🧮 GSK Operating Income Breakdown
Understanding Operating Income
Operating Income, also known as EBIT (Earnings Before Interest and Taxes), measures a company's profit from its core business operations before financing costs and taxes. For GSK, the trailing twelve month operating income is $10.7B.
Why Operating Income Matters
Operating income isolates business performance from capital structure decisions (debt vs equity financing) and tax strategies. This makes it ideal for comparing companies with different debt levels or tax situations. It shows how efficiently management runs the core operations.
GSK's operating income growth rate of N/A (based on log-linear regression of 0 quarters) indicates relatively flat or slightly declining operational performance.
Operating Income vs Other Profitability Metrics
Net Income: $8.5B →
The bottom line after interest and taxes. Net income shows the final profit, while operating income excludes financing decisions.
Free Cash Flow: $8.6B →
Actual cash generated after capital expenditures. FCF can differ significantly from operating income due to working capital and capex.
Owner Earnings: N/A →
Buffett's measure of true cash generation. Adds back depreciation and subtracts only maintenance capex.
Revenue: $44.0B →
The top line that operating income is derived from. Operating margin shows what percentage becomes operational profit.
Operating Margin Analysis
GSK's operating margin of N/A shows what percentage of revenue converts to operating profit after all operating expenses.
EV/Operating Income Valuation
The EV/Operating Income ratio of 22.1x shows how the market values GSK's operational earnings. Ratios between 15-25x suggest investors expect continued growth.
Summary: GSK Operating Income Trend
GSK plc (GSK) generated $10.7B in trailing twelve-month operating income, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring. For complete financial analysis, view the full GSK stock report on Zyberno.
Frequently Asked Questions
What is GSK's current operating income?
GSK plc's TTM operating income is $10.7B, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring.
Is GSK's operating income growing?
GSK plc (GSK) generated $10.7B in trailing twelve-month operating income, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring.
What is GSK's operating margin?
GSK plc (GSK) generated $10.7B in trailing twelve-month operating income, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring.
What is the difference between operating income and EBIT?
Operating income and EBIT (Earnings Before Interest and Taxes) are generally the same metric - both measure profit from core operations before financing costs and taxes. GSK's EBIT/Operating Income is $10.7B.
How does operating income differ from net income?
Operating income excludes interest expense and income taxes, while net income includes them. GSK's operating income is $10.7B versus net income of $8.5B. The difference reflects financing costs and tax burden.
📊 Full GSK Stock Report →
See GSK's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 GSK Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 GSK Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 GSK Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 GSK Earnings Surprise (SUE) →
See whether GSK is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 GSK Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 GSK Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 GSK Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 GSK Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.